nodes	percent_of_prediction	percent_of_DWPC	metapath
Pasireotide—Dry skin—Tacrolimus—atopic dermatitis	0.00219	0.00485	CcSEcCtD
Pasireotide—Hypokalaemia—Tacrolimus—atopic dermatitis	0.00217	0.00481	CcSEcCtD
Pasireotide—Pruritus—Desonide—atopic dermatitis	0.00216	0.00478	CcSEcCtD
Pasireotide—Alopecia—Loratadine—atopic dermatitis	0.00214	0.00473	CcSEcCtD
Pasireotide—Hypotension—Dimenhydrinate—atopic dermatitis	0.00208	0.00462	CcSEcCtD
Pasireotide—Hypotension—Diphenhydramine—atopic dermatitis	0.00208	0.00462	CcSEcCtD
Pasireotide—Abdominal distension—Tacrolimus—atopic dermatitis	0.00208	0.0046	CcSEcCtD
Pasireotide—Influenza—Tacrolimus—atopic dermatitis	0.00206	0.00457	CcSEcCtD
Pasireotide—Insomnia—Diphenhydramine—atopic dermatitis	0.00202	0.00447	CcSEcCtD
Pasireotide—Insomnia—Dimenhydrinate—atopic dermatitis	0.00202	0.00447	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Pimecrolimus—atopic dermatitis	0.00196	0.00435	CcSEcCtD
Pasireotide—Decreased appetite—Dimenhydrinate—atopic dermatitis	0.00194	0.00429	CcSEcCtD
Pasireotide—Decreased appetite—Diphenhydramine—atopic dermatitis	0.00194	0.00429	CcSEcCtD
Pasireotide—Fatigue—Diphenhydramine—atopic dermatitis	0.00192	0.00426	CcSEcCtD
Pasireotide—Fatigue—Dimenhydrinate—atopic dermatitis	0.00192	0.00426	CcSEcCtD
Pasireotide—Alopecia—Fluocinolone Acetonide—atopic dermatitis	0.00192	0.00425	CcSEcCtD
Pasireotide—Headache—Desonide—atopic dermatitis	0.00191	0.00424	CcSEcCtD
Pasireotide—Constipation—Diphenhydramine—atopic dermatitis	0.00191	0.00422	CcSEcCtD
Pasireotide—Constipation—Dimenhydrinate—atopic dermatitis	0.00191	0.00422	CcSEcCtD
Pasireotide—Hyperglycaemia—Tacrolimus—atopic dermatitis	0.00186	0.00412	CcSEcCtD
Pasireotide—Constipation—Pimecrolimus—atopic dermatitis	0.00184	0.00408	CcSEcCtD
Pasireotide—Back pain—Fluocinolone Acetonide—atopic dermatitis	0.00183	0.00405	CcSEcCtD
Pasireotide—Hypertension—Loratadine—atopic dermatitis	0.00182	0.00402	CcSEcCtD
Pasireotide—Myalgia—Loratadine—atopic dermatitis	0.00179	0.00397	CcSEcCtD
Pasireotide—Gastrointestinal pain—Pimecrolimus—atopic dermatitis	0.00176	0.00391	CcSEcCtD
Pasireotide—Diabetes mellitus—Prednisolone—atopic dermatitis	0.00175	0.00388	CcSEcCtD
Pasireotide—Pruritus—Fluocinonide—atopic dermatitis	0.00175	0.00388	CcSEcCtD
Pasireotide—Back pain—Mometasone—atopic dermatitis	0.00175	0.00387	CcSEcCtD
Pasireotide—Diabetes mellitus—Hydrocortisone—atopic dermatitis	0.00171	0.00379	CcSEcCtD
Pasireotide—Abdominal pain—Pimecrolimus—atopic dermatitis	0.0017	0.00378	CcSEcCtD
Pasireotide—Vertigo—Fluocinolone Acetonide—atopic dermatitis	0.0017	0.00376	CcSEcCtD
Pasireotide—Dizziness—Fluocinonide—atopic dermatitis	0.00163	0.00362	CcSEcCtD
Pasireotide—Oedema peripheral—Tacrolimus—atopic dermatitis	0.00163	0.0036	CcSEcCtD
Pasireotide—Hypercholesterolaemia—Prednisone—atopic dermatitis	0.00161	0.00357	CcSEcCtD
Pasireotide—Diabetes mellitus—Triamcinolone—atopic dermatitis	0.00161	0.00357	CcSEcCtD
Pasireotide—Arthralgia—Fluocinolone Acetonide—atopic dermatitis	0.00161	0.00357	CcSEcCtD
Pasireotide—Diabetes mellitus—Methylprednisolone—atopic dermatitis	0.00161	0.00356	CcSEcCtD
Pasireotide—Hypotension—Loratadine—atopic dermatitis	0.0016	0.00356	CcSEcCtD
Pasireotide—Asthenia—Diphenhydramine—atopic dermatitis	0.0016	0.00354	CcSEcCtD
Pasireotide—Asthenia—Dimenhydrinate—atopic dermatitis	0.0016	0.00354	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Loratadine—atopic dermatitis	0.00156	0.00347	CcSEcCtD
Pasireotide—Insomnia—Loratadine—atopic dermatitis	0.00155	0.00344	CcSEcCtD
Pasireotide—Headache—Fluocinonide—atopic dermatitis	0.00155	0.00343	CcSEcCtD
Pasireotide—Arthralgia—Mometasone—atopic dermatitis	0.00154	0.00341	CcSEcCtD
Pasireotide—Myalgia—Mometasone—atopic dermatitis	0.00154	0.00341	CcSEcCtD
Pasireotide—Diarrhoea—Dimenhydrinate—atopic dermatitis	0.00153	0.00338	CcSEcCtD
Pasireotide—Diarrhoea—Diphenhydramine—atopic dermatitis	0.00153	0.00338	CcSEcCtD
Pasireotide—Pruritus—Pimecrolimus—atopic dermatitis	0.00152	0.00338	CcSEcCtD
Pasireotide—Fatigue—Loratadine—atopic dermatitis	0.00148	0.00328	CcSEcCtD
Pasireotide—Diarrhoea—Pimecrolimus—atopic dermatitis	0.00147	0.00327	CcSEcCtD
Pasireotide—Dizziness—Dimenhydrinate—atopic dermatitis	0.00147	0.00327	CcSEcCtD
Pasireotide—Dizziness—Diphenhydramine—atopic dermatitis	0.00147	0.00327	CcSEcCtD
Pasireotide—Constipation—Loratadine—atopic dermatitis	0.00147	0.00325	CcSEcCtD
Pasireotide—Diabetes mellitus—Dexamethasone—atopic dermatitis	0.00146	0.00324	CcSEcCtD
Pasireotide—Diabetes mellitus—Betamethasone—atopic dermatitis	0.00146	0.00324	CcSEcCtD
Pasireotide—Alopecia—Tacrolimus—atopic dermatitis	0.00146	0.00323	CcSEcCtD
Pasireotide—Vomiting—Diphenhydramine—atopic dermatitis	0.00142	0.00314	CcSEcCtD
Pasireotide—Vomiting—Dimenhydrinate—atopic dermatitis	0.00142	0.00314	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Fluocinolone Acetonide—atopic dermatitis	0.00141	0.00312	CcSEcCtD
Pasireotide—Gastrointestinal pain—Loratadine—atopic dermatitis	0.0014	0.00311	CcSEcCtD
Pasireotide—Dry skin—Prednisolone—atopic dermatitis	0.0014	0.0031	CcSEcCtD
Pasireotide—Headache—Dimenhydrinate—atopic dermatitis	0.0014	0.00309	CcSEcCtD
Pasireotide—Headache—Diphenhydramine—atopic dermatitis	0.0014	0.00309	CcSEcCtD
Pasireotide—Back pain—Tacrolimus—atopic dermatitis	0.00139	0.00308	CcSEcCtD
Pasireotide—Vomiting—Pimecrolimus—atopic dermatitis	0.00137	0.00304	CcSEcCtD
Pasireotide—Dry skin—Hydrocortisone—atopic dermatitis	0.00136	0.00302	CcSEcCtD
Pasireotide—Abdominal pain upper—Hydrocortisone—atopic dermatitis	0.00136	0.00301	CcSEcCtD
Pasireotide—Abdominal pain—Loratadine—atopic dermatitis	0.00136	0.00301	CcSEcCtD
Pasireotide—Hypokalaemia—Hydrocortisone—atopic dermatitis	0.00135	0.003	CcSEcCtD
Pasireotide—Headache—Pimecrolimus—atopic dermatitis	0.00135	0.00299	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Mometasone—atopic dermatitis	0.00134	0.00297	CcSEcCtD
Pasireotide—Anaemia—Tacrolimus—atopic dermatitis	0.00133	0.00294	CcSEcCtD
Pasireotide—Abdominal distension—Prednisolone—atopic dermatitis	0.00133	0.00294	CcSEcCtD
Pasireotide—Nausea—Dimenhydrinate—atopic dermatitis	0.00132	0.00293	CcSEcCtD
Pasireotide—Nausea—Diphenhydramine—atopic dermatitis	0.00132	0.00293	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Hydrocortisone—atopic dermatitis	0.00131	0.00291	CcSEcCtD
Pasireotide—SSTR5—GPCR ligand binding—CCR3—atopic dermatitis	0.0013	0.00237	CbGpPWpGaD
Pasireotide—Abdominal distension—Hydrocortisone—atopic dermatitis	0.00129	0.00287	CcSEcCtD
Pasireotide—Vertigo—Tacrolimus—atopic dermatitis	0.00129	0.00286	CcSEcCtD
Pasireotide—SSTR2—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.00129	0.00235	CbGpPWpGaD
Pasireotide—SSTR3—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.00128	0.00234	CbGpPWpGaD
Pasireotide—SSTR1—GPCR ligand binding—CXCR3—atopic dermatitis	0.00128	0.00233	CbGpPWpGaD
Pasireotide—Decreased appetite—Mometasone—atopic dermatitis	0.00128	0.00284	CcSEcCtD
Pasireotide—Nausea—Pimecrolimus—atopic dermatitis	0.00128	0.00284	CcSEcCtD
Pasireotide—SSTR1—Signaling by GPCR—CCL27—atopic dermatitis	0.00128	0.00233	CbGpPWpGaD
Pasireotide—Diabetes mellitus—Prednisone—atopic dermatitis	0.00127	0.00282	CcSEcCtD
Pasireotide—SSTR5—Signaling by GPCR—CCL22—atopic dermatitis	0.00127	0.00231	CbGpPWpGaD
Pasireotide—Fatigue—Mometasone—atopic dermatitis	0.00127	0.00282	CcSEcCtD
Pasireotide—SSTR5—GPCR downstream signaling—CCL27—atopic dermatitis	0.00125	0.00227	CbGpPWpGaD
Pasireotide—Hypertension—Tacrolimus—atopic dermatitis	0.00124	0.00275	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Methylprednisolone—atopic dermatitis	0.00123	0.00273	CcSEcCtD
Pasireotide—Asthenia—Loratadine—atopic dermatitis	0.00123	0.00273	CcSEcCtD
Pasireotide—SSTR1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.00123	0.00224	CbGpPWpGaD
Pasireotide—Arthralgia—Tacrolimus—atopic dermatitis	0.00122	0.00271	CcSEcCtD
Pasireotide—Myalgia—Tacrolimus—atopic dermatitis	0.00122	0.00271	CcSEcCtD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.00122	0.00223	CbGpPWpGaD
Pasireotide—Abdominal distension—Triamcinolone—atopic dermatitis	0.00122	0.0027	CcSEcCtD
Pasireotide—Anxiety—Tacrolimus—atopic dermatitis	0.00122	0.0027	CcSEcCtD
Pasireotide—Abdominal distension—Methylprednisolone—atopic dermatitis	0.00122	0.0027	CcSEcCtD
Pasireotide—Influenza—Triamcinolone—atopic dermatitis	0.00121	0.00268	CcSEcCtD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.00121	0.0022	CbGpPWpGaD
Pasireotide—SSTR2—G alpha (i) signalling events—CCL5—atopic dermatitis	0.00121	0.0022	CbGpPWpGaD
Pasireotide—Gastrointestinal pain—Mometasone—atopic dermatitis	0.0012	0.00267	CcSEcCtD
Pasireotide—SSTR2—GPCR ligand binding—CCR3—atopic dermatitis	0.0012	0.00219	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—CCL17—atopic dermatitis	0.00119	0.00218	CbGpPWpGaD
Pasireotide—SSTR5—G alpha (i) signalling events—CCR5—atopic dermatitis	0.00118	0.00214	CbGpPWpGaD
Pasireotide—Diarrhoea—Loratadine—atopic dermatitis	0.00117	0.0026	CcSEcCtD
Pasireotide—SSTR2—Signaling by GPCR—CCL22—atopic dermatitis	0.00117	0.00214	CbGpPWpGaD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.00117	0.00213	CbGpPWpGaD
Pasireotide—Dry skin—Betamethasone—atopic dermatitis	0.00117	0.00258	CcSEcCtD
Pasireotide—Dry skin—Dexamethasone—atopic dermatitis	0.00117	0.00258	CcSEcCtD
Pasireotide—Abdominal pain—Mometasone—atopic dermatitis	0.00116	0.00258	CcSEcCtD
Pasireotide—SSTR5—GPCR ligand binding—NPS—atopic dermatitis	0.00116	0.00211	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—TAC1—atopic dermatitis	0.00116	0.00211	CbGpPWpGaD
Pasireotide—Hypokalaemia—Betamethasone—atopic dermatitis	0.00116	0.00256	CcSEcCtD
Pasireotide—Hypokalaemia—Dexamethasone—atopic dermatitis	0.00116	0.00256	CcSEcCtD
Pasireotide—SSTR2—GPCR downstream signaling—CCL27—atopic dermatitis	0.00115	0.0021	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—CCL17—atopic dermatitis	0.00114	0.00209	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—CXCR3—atopic dermatitis	0.00114	0.00207	CbGpPWpGaD
Pasireotide—Dizziness—Loratadine—atopic dermatitis	0.00114	0.00252	CcSEcCtD
Pasireotide—SSTR5—Signaling by GPCR—CCL27—atopic dermatitis	0.00113	0.00206	CbGpPWpGaD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.00111	0.00203	CbGpPWpGaD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—CXCL8—atopic dermatitis	0.00111	0.00203	CbGpPWpGaD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.0011	0.002	CbGpPWpGaD
Pasireotide—Hypotension—Tacrolimus—atopic dermatitis	0.0011	0.00243	CcSEcCtD
Pasireotide—SSTR5—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.00109	0.00199	CbGpPWpGaD
Pasireotide—Pruritus—Fluocinolone Acetonide—atopic dermatitis	0.00109	0.00242	CcSEcCtD
Pasireotide—Vomiting—Loratadine—atopic dermatitis	0.00109	0.00242	CcSEcCtD
Pasireotide—SSTR2—G alpha (i) signalling events—CCR5—atopic dermatitis	0.00109	0.00198	CbGpPWpGaD
Pasireotide—SSTR3—GPCR ligand binding—CXCL10—atopic dermatitis	0.00108	0.00197	CbGpPWpGaD
Pasireotide—Headache—Loratadine—atopic dermatitis	0.00108	0.00238	CcSEcCtD
Pasireotide—SSTR2—GPCR ligand binding—NPS—atopic dermatitis	0.00107	0.00195	CbGpPWpGaD
Pasireotide—SSTR2—GPCR ligand binding—TAC1—atopic dermatitis	0.00107	0.00195	CbGpPWpGaD
Pasireotide—Musculoskeletal discomfort—Tacrolimus—atopic dermatitis	0.00107	0.00237	CcSEcCtD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	0.00107	0.00195	CbGpPWpGaD
Pasireotide—Insomnia—Tacrolimus—atopic dermatitis	0.00106	0.00235	CcSEcCtD
Pasireotide—Asthenia—Mometasone—atopic dermatitis	0.00106	0.00234	CcSEcCtD
Pasireotide—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.00106	0.00234	CcSEcCtD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.00105	0.00192	CbGpPWpGaD
Pasireotide—SSTR2—GPCR ligand binding—CXCR3—atopic dermatitis	0.00105	0.00191	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—CCL27—atopic dermatitis	0.00104	0.0019	CbGpPWpGaD
Pasireotide—Pruritus—Mometasone—atopic dermatitis	0.00104	0.00231	CcSEcCtD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.00104	0.00189	CbGpPWpGaD
Pasireotide—SSTR1—GPCR ligand binding—CXCL10—atopic dermatitis	0.00104	0.00189	CbGpPWpGaD
Pasireotide—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.00102	0.00226	CcSEcCtD
Pasireotide—Nausea—Loratadine—atopic dermatitis	0.00102	0.00226	CcSEcCtD
Pasireotide—Decreased appetite—Tacrolimus—atopic dermatitis	0.00102	0.00226	CcSEcCtD
Pasireotide—SSTR5—Signaling by GPCR—CCL17—atopic dermatitis	0.00102	0.00185	CbGpPWpGaD
Pasireotide—Dry skin—Prednisone—atopic dermatitis	0.00101	0.00225	CcSEcCtD
Pasireotide—Fatigue—Tacrolimus—atopic dermatitis	0.00101	0.00224	CcSEcCtD
Pasireotide—Diarrhoea—Mometasone—atopic dermatitis	0.00101	0.00223	CcSEcCtD
Pasireotide—Hypokalaemia—Prednisone—atopic dermatitis	0.00101	0.00223	CcSEcCtD
Pasireotide—SSTR2—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.00101	0.00184	CbGpPWpGaD
Pasireotide—Constipation—Tacrolimus—atopic dermatitis	0.001	0.00222	CcSEcCtD
Pasireotide—SSTR3—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.000992	0.00181	CbGpPWpGaD
Pasireotide—Hyperglycaemia—Betamethasone—atopic dermatitis	0.000991	0.0022	CcSEcCtD
Pasireotide—Hyperglycaemia—Dexamethasone—atopic dermatitis	0.000991	0.0022	CcSEcCtD
Pasireotide—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000981	0.00217	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Prednisone—atopic dermatitis	0.000977	0.00216	CcSEcCtD
Pasireotide—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000967	0.00214	CcSEcCtD
Pasireotide—Abdominal distension—Prednisone—atopic dermatitis	0.000963	0.00214	CcSEcCtD
Pasireotide—SSTR3—Signaling by GPCR—CCL11—atopic dermatitis	0.000963	0.00175	CbGpPWpGaD
Pasireotide—Gastrointestinal pain—Tacrolimus—atopic dermatitis	0.000959	0.00213	CcSEcCtD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000958	0.00175	CbGpPWpGaD
Pasireotide—SSTR1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.000951	0.00173	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—FCER2—atopic dermatitis	0.000949	0.00173	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—CCL17—atopic dermatitis	0.000937	0.00171	CbGpPWpGaD
Pasireotide—Vomiting—Mometasone—atopic dermatitis	0.000937	0.00208	CcSEcCtD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000935	0.0017	CbGpPWpGaD
Pasireotide—SSTR3—GPCR ligand binding—CCL5—atopic dermatitis	0.00093	0.00169	CbGpPWpGaD
Pasireotide—Abdominal pain—Tacrolimus—atopic dermatitis	0.000927	0.00205	CcSEcCtD
Pasireotide—Headache—Mometasone—atopic dermatitis	0.000923	0.00205	CcSEcCtD
Pasireotide—SSTR1—Signaling by GPCR—CCL11—atopic dermatitis	0.000923	0.00168	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—CXCL10—atopic dermatitis	0.000919	0.00167	CbGpPWpGaD
Pasireotide—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000916	0.00203	CcSEcCtD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—CXCL8—atopic dermatitis	0.000911	0.00166	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—FCER2—atopic dermatitis	0.00091	0.00166	CbGpPWpGaD
Pasireotide—SSTR1—GPCR ligand binding—CCL5—atopic dermatitis	0.000892	0.00162	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CCL22—atopic dermatitis	0.000882	0.00161	CbGpPWpGaD
Pasireotide—Nausea—Mometasone—atopic dermatitis	0.000875	0.00194	CcSEcCtD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	0.000874	0.00159	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—CCR3—atopic dermatitis	0.000864	0.00157	CbGpPWpGaD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000863	0.00157	CbGpPWpGaD
Pasireotide—Hyperglycaemia—Prednisone—atopic dermatitis	0.000863	0.00191	CcSEcCtD
Pasireotide—SSTR2—GPCR ligand binding—CXCL10—atopic dermatitis	0.000848	0.00154	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CCL22—atopic dermatitis	0.000846	0.00154	CbGpPWpGaD
Pasireotide—SSTR5—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.000843	0.00154	CbGpPWpGaD
Pasireotide—Asthenia—Tacrolimus—atopic dermatitis	0.000841	0.00186	CcSEcCtD
Pasireotide—SSTR3—GPCR ligand binding—CCR5—atopic dermatitis	0.000838	0.00153	CbGpPWpGaD
Pasireotide—SSTR3—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.000837	0.00152	CbGpPWpGaD
Pasireotide—Pruritus—Tacrolimus—atopic dermatitis	0.00083	0.00184	CcSEcCtD
Pasireotide—SSTR1—GPCR downstream signaling—CCR3—atopic dermatitis	0.000828	0.00151	CbGpPWpGaD
Pasireotide—Vertigo—Prednisolone—atopic dermatitis	0.000824	0.00183	CcSEcCtD
Pasireotide—SSTR5—Signaling by GPCR—CCL11—atopic dermatitis	0.000818	0.00149	CbGpPWpGaD
Pasireotide—Back pain—Triamcinolone—atopic dermatitis	0.000816	0.00181	CcSEcCtD
Pasireotide—SSTR5—Signaling Pathways—FCER2—atopic dermatitis	0.000807	0.00147	CbGpPWpGaD
Pasireotide—Vertigo—Hydrocortisone—atopic dermatitis	0.000805	0.00178	CcSEcCtD
Pasireotide—SSTR1—GPCR ligand binding—CCR5—atopic dermatitis	0.000803	0.00146	CbGpPWpGaD
Pasireotide—Diarrhoea—Tacrolimus—atopic dermatitis	0.000802	0.00178	CcSEcCtD
Pasireotide—SSTR1—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.000802	0.00146	CbGpPWpGaD
Pasireotide—Hypertension—Prednisolone—atopic dermatitis	0.000792	0.00176	CcSEcCtD
Pasireotide—SSTR5—GPCR ligand binding—CCL5—atopic dermatitis	0.000791	0.00144	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CCL27—atopic dermatitis	0.000786	0.00143	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—CCR3—atopic dermatitis	0.000785	0.00143	CbGpPWpGaD
Pasireotide—SSTR2—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.000778	0.00142	CbGpPWpGaD
Pasireotide—Alopecia—Betamethasone—atopic dermatitis	0.000777	0.00172	CcSEcCtD
Pasireotide—Alopecia—Dexamethasone—atopic dermatitis	0.000777	0.00172	CcSEcCtD
Pasireotide—Dizziness—Tacrolimus—atopic dermatitis	0.000775	0.00172	CcSEcCtD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—TNF—atopic dermatitis	0.000775	0.00141	CbGpPWpGaD
Pasireotide—Hypertension—Hydrocortisone—atopic dermatitis	0.000774	0.00171	CcSEcCtD
Pasireotide—SSTR3—GPCR downstream signaling—NPS—atopic dermatitis	0.00077	0.0014	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—TAC1—atopic dermatitis	0.00077	0.0014	CbGpPWpGaD
Pasireotide—Myalgia—Hydrocortisone—atopic dermatitis	0.000763	0.00169	CcSEcCtD
Pasireotide—Anxiety—Hydrocortisone—atopic dermatitis	0.00076	0.00169	CcSEcCtD
Pasireotide—Vertigo—Triamcinolone—atopic dermatitis	0.000758	0.00168	CcSEcCtD
Pasireotide—Vertigo—Methylprednisolone—atopic dermatitis	0.000756	0.00168	CcSEcCtD
Pasireotide—SSTR2—Signaling by GPCR—CCL11—atopic dermatitis	0.000755	0.00138	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000755	0.00138	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CCL27—atopic dermatitis	0.000754	0.00137	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—CCR3—atopic dermatitis	0.000752	0.00137	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CCL22—atopic dermatitis	0.00075	0.00137	CbGpPWpGaD
Pasireotide—Vomiting—Tacrolimus—atopic dermatitis	0.000745	0.00165	CcSEcCtD
Pasireotide—SSTR2—Signaling Pathways—FCER2—atopic dermatitis	0.000745	0.00136	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—TAC1—atopic dermatitis	0.000738	0.00135	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—NPS—atopic dermatitis	0.000738	0.00135	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—CCR3—atopic dermatitis	0.000735	0.00134	CbGpPWpGaD
Pasireotide—Headache—Tacrolimus—atopic dermatitis	0.000735	0.00163	CcSEcCtD
Pasireotide—SSTR2—GPCR ligand binding—CCL5—atopic dermatitis	0.00073	0.00133	CbGpPWpGaD
Pasireotide—Hypertension—Triamcinolone—atopic dermatitis	0.000729	0.00161	CcSEcCtD
Pasireotide—Hypertension—Methylprednisolone—atopic dermatitis	0.000727	0.00161	CcSEcCtD
Pasireotide—SSTR1—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000724	0.00132	CbGpPWpGaD
Pasireotide—Myalgia—Triamcinolone—atopic dermatitis	0.000718	0.00159	CcSEcCtD
Pasireotide—Myalgia—Methylprednisolone—atopic dermatitis	0.000717	0.00159	CcSEcCtD
Pasireotide—Arthralgia—Methylprednisolone—atopic dermatitis	0.000717	0.00159	CcSEcCtD
Pasireotide—SSTR3—GPCR downstream signaling—IL5—atopic dermatitis	0.000716	0.0013	CbGpPWpGaD
Pasireotide—Anxiety—Methylprednisolone—atopic dermatitis	0.000714	0.00158	CcSEcCtD
Pasireotide—SSTR5—GPCR ligand binding—CCR5—atopic dermatitis	0.000712	0.0013	CbGpPWpGaD
Pasireotide—SSTR5—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.000711	0.0013	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CCL17—atopic dermatitis	0.000705	0.00129	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—TAC1—atopic dermatitis	0.000699	0.00127	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—NPS—atopic dermatitis	0.000699	0.00127	CbGpPWpGaD
Pasireotide—Nausea—Tacrolimus—atopic dermatitis	0.000696	0.00154	CcSEcCtD
Pasireotide—SSTR2—Signaling Pathways—CCL22—atopic dermatitis	0.000692	0.00126	CbGpPWpGaD
Pasireotide—Vertigo—Betamethasone—atopic dermatitis	0.000688	0.00152	CcSEcCtD
Pasireotide—Vertigo—Dexamethasone—atopic dermatitis	0.000688	0.00152	CcSEcCtD
Pasireotide—SSTR1—GPCR downstream signaling—IL5—atopic dermatitis	0.000686	0.00125	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—CXCR3—atopic dermatitis	0.000686	0.00125	CbGpPWpGaD
Pasireotide—Hypotension—Hydrocortisone—atopic dermatitis	0.000683	0.00151	CcSEcCtD
Pasireotide—SSTR2—GPCR downstream signaling—CCR3—atopic dermatitis	0.000678	0.00124	CbGpPWpGaD
Pasireotide—Insomnia—Prednisolone—atopic dermatitis	0.000677	0.0015	CcSEcCtD
Pasireotide—Alopecia—Prednisone—atopic dermatitis	0.000677	0.0015	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—CCL17—atopic dermatitis	0.000676	0.00123	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—NPS—atopic dermatitis	0.000671	0.00122	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—TAC1—atopic dermatitis	0.000671	0.00122	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CCL27—atopic dermatitis	0.000669	0.00122	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—CCR3—atopic dermatitis	0.000667	0.00122	CbGpPWpGaD
Pasireotide—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000666	0.00148	CcSEcCtD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000665	0.00121	CbGpPWpGaD
Pasireotide—Insomnia—Hydrocortisone—atopic dermatitis	0.000662	0.00147	CcSEcCtD
Pasireotide—Hypertension—Dexamethasone—atopic dermatitis	0.000661	0.00147	CcSEcCtD
Pasireotide—Hypertension—Betamethasone—atopic dermatitis	0.000661	0.00147	CcSEcCtD
Pasireotide—SSTR1—Signaling by GPCR—CXCR3—atopic dermatitis	0.000658	0.0012	CbGpPWpGaD
Pasireotide—SSTR2—GPCR ligand binding—CCR5—atopic dermatitis	0.000657	0.0012	CbGpPWpGaD
Pasireotide—SSTR2—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.000656	0.0012	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—NPS—atopic dermatitis	0.000655	0.00119	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—TAC1—atopic dermatitis	0.000655	0.00119	CbGpPWpGaD
Pasireotide—Myalgia—Betamethasone—atopic dermatitis	0.000652	0.00144	CcSEcCtD
Pasireotide—Myalgia—Dexamethasone—atopic dermatitis	0.000652	0.00144	CcSEcCtD
Pasireotide—SSTR3—Signaling by GPCR—IL5—atopic dermatitis	0.00065	0.00118	CbGpPWpGaD
Pasireotide—Anxiety—Dexamethasone—atopic dermatitis	0.00065	0.00144	CcSEcCtD
Pasireotide—Anxiety—Betamethasone—atopic dermatitis	0.00065	0.00144	CcSEcCtD
Pasireotide—SSTR5—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000642	0.00117	CbGpPWpGaD
Pasireotide—Hypotension—Methylprednisolone—atopic dermatitis	0.000642	0.00142	CcSEcCtD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000638	0.00116	CbGpPWpGaD
Pasireotide—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000636	0.00141	CcSEcCtD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—TNF—atopic dermatitis	0.000634	0.00116	CbGpPWpGaD
Pasireotide—Fatigue—Hydrocortisone—atopic dermatitis	0.000631	0.0014	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—KIF3A—atopic dermatitis	0.000629	0.00115	CbGpPWpGaD
Pasireotide—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.000627	0.00139	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000626	0.00139	CcSEcCtD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—IL6—atopic dermatitis	0.000625	0.00114	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—IL5—atopic dermatitis	0.000623	0.00114	CbGpPWpGaD
Pasireotide—Insomnia—Triamcinolone—atopic dermatitis	0.000623	0.00138	CcSEcCtD
Pasireotide—Insomnia—Methylprednisolone—atopic dermatitis	0.000622	0.00138	CcSEcCtD
Pasireotide—SSTR2—Signaling Pathways—CCL27—atopic dermatitis	0.000617	0.00112	CbGpPWpGaD
Pasireotide—Anaemia—Prednisone—atopic dermatitis	0.000616	0.00137	CcSEcCtD
Pasireotide—SSTR2—Signaling by GPCR—CCR3—atopic dermatitis	0.000616	0.00112	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—CXCL10—atopic dermatitis	0.00061	0.00111	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—IL5—atopic dermatitis	0.000609	0.00111	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—TAC1—atopic dermatitis	0.000604	0.0011	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—NPS—atopic dermatitis	0.000604	0.0011	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—KIF3A—atopic dermatitis	0.000603	0.0011	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CCL17—atopic dermatitis	0.0006	0.00109	CbGpPWpGaD
Pasireotide—Vertigo—Prednisone—atopic dermatitis	0.000599	0.00133	CcSEcCtD
Pasireotide—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000598	0.00133	CcSEcCtD
Pasireotide—SSTR5—Signaling by GPCR—TAC1—atopic dermatitis	0.000595	0.00108	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—NPS—atopic dermatitis	0.000595	0.00108	CbGpPWpGaD
Pasireotide—Fatigue—Triamcinolone—atopic dermatitis	0.000594	0.00132	CcSEcCtD
Pasireotide—SSTR2—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000593	0.00108	CbGpPWpGaD
Pasireotide—Fatigue—Methylprednisolone—atopic dermatitis	0.000592	0.00131	CcSEcCtD
Pasireotide—SSTR1—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000585	0.00107	CbGpPWpGaD
Pasireotide—Hypotension—Betamethasone—atopic dermatitis	0.000584	0.00129	CcSEcCtD
Pasireotide—Hypotension—Dexamethasone—atopic dermatitis	0.000584	0.00129	CcSEcCtD
Pasireotide—SSTR5—Signaling by GPCR—CXCR3—atopic dermatitis	0.000583	0.00106	CbGpPWpGaD
Pasireotide—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000578	0.00128	CcSEcCtD
Pasireotide—Hypertension—Prednisone—atopic dermatitis	0.000576	0.00128	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.000569	0.00126	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.000569	0.00126	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—CCL11—atopic dermatitis	0.000569	0.00104	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CMA1—atopic dermatitis	0.000569	0.00104	CbGpPWpGaD
Pasireotide—Myalgia—Prednisone—atopic dermatitis	0.000568	0.00126	CcSEcCtD
Pasireotide—Arthralgia—Prednisone—atopic dermatitis	0.000568	0.00126	CcSEcCtD
Pasireotide—Anxiety—Prednisone—atopic dermatitis	0.000566	0.00125	CcSEcCtD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000566	0.00103	CbGpPWpGaD
Pasireotide—Insomnia—Dexamethasone—atopic dermatitis	0.000565	0.00125	CcSEcCtD
Pasireotide—Insomnia—Betamethasone—atopic dermatitis	0.000565	0.00125	CcSEcCtD
Pasireotide—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000562	0.00125	CcSEcCtD
Pasireotide—SSTR2—GPCR downstream signaling—IL5—atopic dermatitis	0.000562	0.00102	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—CXCL10—atopic dermatitis	0.000554	0.00101	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CCL17—atopic dermatitis	0.000554	0.00101	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—IL5—atopic dermatitis	0.000553	0.00101	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—TAC1—atopic dermatitis	0.000549	0.001	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—NPS—atopic dermatitis	0.000549	0.001	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CMA1—atopic dermatitis	0.000545	0.000993	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CCL11—atopic dermatitis	0.000545	0.000993	CbGpPWpGaD
Pasireotide—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000543	0.0012	CcSEcCtD
Pasireotide—Decreased appetite—Dexamethasone—atopic dermatitis	0.000543	0.0012	CcSEcCtD
Pasireotide—Decreased appetite—Betamethasone—atopic dermatitis	0.000543	0.0012	CcSEcCtD
Pasireotide—Fatigue—Dexamethasone—atopic dermatitis	0.000539	0.00119	CcSEcCtD
Pasireotide—Fatigue—Betamethasone—atopic dermatitis	0.000539	0.00119	CcSEcCtD
Pasireotide—SSTR2—Signaling by GPCR—CXCR3—atopic dermatitis	0.000538	0.000981	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—STAT6—atopic dermatitis	0.000535	0.000974	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—KIF3A—atopic dermatitis	0.000535	0.000974	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—CXCL10—atopic dermatitis	0.000532	0.000968	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—CCL5—atopic dermatitis	0.000526	0.000958	CbGpPWpGaD
Pasireotide—Asthenia—Hydrocortisone—atopic dermatitis	0.000525	0.00116	CcSEcCtD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000522	0.000951	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000519	0.000946	CbGpPWpGaD
Pasireotide—Pruritus—Hydrocortisone—atopic dermatitis	0.000517	0.00115	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—STAT6—atopic dermatitis	0.000513	0.000934	CbGpPWpGaD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—IL6—atopic dermatitis	0.000512	0.000932	CbGpPWpGaD
Pasireotide—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000511	0.00113	CcSEcCtD
Pasireotide—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000511	0.00113	CcSEcCtD
Pasireotide—SSTR2—Signaling by GPCR—IL5—atopic dermatitis	0.00051	0.00093	CbGpPWpGaD
Pasireotide—SSTR3—GPCR ligand binding—CXCL8—atopic dermatitis	0.000507	0.000923	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—CCL5—atopic dermatitis	0.000504	0.000918	CbGpPWpGaD
Pasireotide—Diarrhoea—Hydrocortisone—atopic dermatitis	0.0005	0.00111	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Prednisone—atopic dermatitis	0.000496	0.0011	CcSEcCtD
Pasireotide—Dizziness—Prednisolone—atopic dermatitis	0.000495	0.0011	CcSEcCtD
Pasireotide—Asthenia—Triamcinolone—atopic dermatitis	0.000494	0.0011	CcSEcCtD
Pasireotide—Abdominal pain—Dexamethasone—atopic dermatitis	0.000494	0.00109	CcSEcCtD
Pasireotide—Abdominal pain—Betamethasone—atopic dermatitis	0.000494	0.00109	CcSEcCtD
Pasireotide—SSTR2—Signaling Pathways—KIF3A—atopic dermatitis	0.000493	0.000899	CbGpPWpGaD
Pasireotide—Asthenia—Methylprednisolone—atopic dermatitis	0.000493	0.00109	CcSEcCtD
Pasireotide—Insomnia—Prednisone—atopic dermatitis	0.000492	0.00109	CcSEcCtD
Pasireotide—Pruritus—Triamcinolone—atopic dermatitis	0.000487	0.00108	CcSEcCtD
Pasireotide—Pruritus—Methylprednisolone—atopic dermatitis	0.000486	0.00108	CcSEcCtD
Pasireotide—SSTR1—GPCR ligand binding—CXCL8—atopic dermatitis	0.000486	0.000885	CbGpPWpGaD
Pasireotide—Dizziness—Hydrocortisone—atopic dermatitis	0.000484	0.00107	CcSEcCtD
Pasireotide—SSTR5—Signaling Pathways—CCL11—atopic dermatitis	0.000483	0.000881	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CMA1—atopic dermatitis	0.000483	0.000881	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000479	0.000873	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—CCL5—atopic dermatitis	0.000477	0.00087	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—CCR5—atopic dermatitis	0.000473	0.000863	CbGpPWpGaD
Pasireotide—Decreased appetite—Prednisone—atopic dermatitis	0.000473	0.00105	CcSEcCtD
Pasireotide—SSTR5—Signaling by GPCR—CXCL10—atopic dermatitis	0.000471	0.000859	CbGpPWpGaD
Pasireotide—Diarrhoea—Methylprednisolone—atopic dermatitis	0.00047	0.00104	CcSEcCtD
Pasireotide—Fatigue—Prednisone—atopic dermatitis	0.000469	0.00104	CcSEcCtD
Pasireotide—Headache—Prednisolone—atopic dermatitis	0.000469	0.00104	CcSEcCtD
Pasireotide—Constipation—Prednisone—atopic dermatitis	0.000465	0.00103	CcSEcCtD
Pasireotide—Vomiting—Hydrocortisone—atopic dermatitis	0.000465	0.00103	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—CCR3—atopic dermatitis	0.000464	0.000845	CbGpPWpGaD
Pasireotide—Headache—Hydrocortisone—atopic dermatitis	0.000458	0.00102	CcSEcCtD
Pasireotide—SSTR1—Signaling by GPCR—CCL5—atopic dermatitis	0.000458	0.000834	CbGpPWpGaD
Pasireotide—Dizziness—Triamcinolone—atopic dermatitis	0.000455	0.00101	CcSEcCtD
Pasireotide—SSTR5—Signaling Pathways—STAT6—atopic dermatitis	0.000455	0.000828	CbGpPWpGaD
Pasireotide—Dizziness—Methylprednisolone—atopic dermatitis	0.000454	0.00101	CcSEcCtD
Pasireotide—SSTR1—GPCR downstream signaling—CCR5—atopic dermatitis	0.000454	0.000827	CbGpPWpGaD
Pasireotide—Asthenia—Dexamethasone—atopic dermatitis	0.000448	0.000994	CcSEcCtD
Pasireotide—Asthenia—Betamethasone—atopic dermatitis	0.000448	0.000994	CcSEcCtD
Pasireotide—SSTR5—GPCR downstream signaling—CCL5—atopic dermatitis	0.000447	0.000814	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CCL11—atopic dermatitis	0.000446	0.000813	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CMA1—atopic dermatitis	0.000446	0.000813	CbGpPWpGaD
Pasireotide—Gastrointestinal pain—Prednisone—atopic dermatitis	0.000445	0.000986	CcSEcCtD
Pasireotide—Nausea—Prednisolone—atopic dermatitis	0.000445	0.000986	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—CCR3—atopic dermatitis	0.000444	0.00081	CbGpPWpGaD
Pasireotide—Pruritus—Dexamethasone—atopic dermatitis	0.000442	0.00098	CcSEcCtD
Pasireotide—Pruritus—Betamethasone—atopic dermatitis	0.000442	0.00098	CcSEcCtD
Pasireotide—Vomiting—Triamcinolone—atopic dermatitis	0.000438	0.000971	CcSEcCtD
Pasireotide—Vomiting—Methylprednisolone—atopic dermatitis	0.000437	0.000968	CcSEcCtD
Pasireotide—SSTR2—Signaling by GPCR—CXCL10—atopic dermatitis	0.000435	0.000793	CbGpPWpGaD
Pasireotide—Nausea—Hydrocortisone—atopic dermatitis	0.000434	0.000963	CcSEcCtD
Pasireotide—Headache—Triamcinolone—atopic dermatitis	0.000431	0.000956	CcSEcCtD
Pasireotide—SSTR5—GPCR ligand binding—CXCL8—atopic dermatitis	0.000431	0.000785	CbGpPWpGaD
Pasireotide—Headache—Methylprednisolone—atopic dermatitis	0.00043	0.000954	CcSEcCtD
Pasireotide—Abdominal pain—Prednisone—atopic dermatitis	0.00043	0.000954	CcSEcCtD
Pasireotide—SSTR3—Signaling by GPCR—CCR5—atopic dermatitis	0.00043	0.000783	CbGpPWpGaD
Pasireotide—Diarrhoea—Dexamethasone—atopic dermatitis	0.000428	0.000948	CcSEcCtD
Pasireotide—Diarrhoea—Betamethasone—atopic dermatitis	0.000428	0.000948	CcSEcCtD
Pasireotide—SSTR2—Signaling Pathways—STAT6—atopic dermatitis	0.00042	0.000764	CbGpPWpGaD
Pasireotide—Dizziness—Betamethasone—atopic dermatitis	0.000413	0.000916	CcSEcCtD
Pasireotide—Dizziness—Dexamethasone—atopic dermatitis	0.000413	0.000916	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—TAC1—atopic dermatitis	0.000413	0.000753	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—NPS—atopic dermatitis	0.000413	0.000753	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—CCL5—atopic dermatitis	0.000412	0.000751	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—CCR5—atopic dermatitis	0.000412	0.000751	CbGpPWpGaD
Pasireotide—Nausea—Triamcinolone—atopic dermatitis	0.000409	0.000907	CcSEcCtD
Pasireotide—Nausea—Methylprednisolone—atopic dermatitis	0.000408	0.000905	CcSEcCtD
Pasireotide—SSTR5—Signaling by GPCR—CCL5—atopic dermatitis	0.000406	0.000739	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CXCR3—atopic dermatitis	0.000405	0.000738	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—CCR5—atopic dermatitis	0.000403	0.000733	CbGpPWpGaD
Pasireotide—SSTR2—GPCR ligand binding—CXCL8—atopic dermatitis	0.000397	0.000724	CbGpPWpGaD
Pasireotide—Vomiting—Dexamethasone—atopic dermatitis	0.000397	0.000881	CcSEcCtD
Pasireotide—Vomiting—Betamethasone—atopic dermatitis	0.000397	0.000881	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—TAC1—atopic dermatitis	0.000396	0.000722	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—NPS—atopic dermatitis	0.000396	0.000722	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CCR3—atopic dermatitis	0.000394	0.000718	CbGpPWpGaD
Pasireotide—Headache—Dexamethasone—atopic dermatitis	0.000391	0.000868	CcSEcCtD
Pasireotide—Headache—Betamethasone—atopic dermatitis	0.000391	0.000868	CcSEcCtD
Pasireotide—Asthenia—Prednisone—atopic dermatitis	0.00039	0.000865	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—CXCR3—atopic dermatitis	0.000388	0.000708	CbGpPWpGaD
Pasireotide—Pruritus—Prednisone—atopic dermatitis	0.000385	0.000853	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—IL5—atopic dermatitis	0.000384	0.0007	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—CCL5—atopic dermatitis	0.000374	0.000682	CbGpPWpGaD
Pasireotide—Diarrhoea—Prednisone—atopic dermatitis	0.000372	0.000825	CcSEcCtD
Pasireotide—SSTR2—GPCR downstream signaling—CCR5—atopic dermatitis	0.000372	0.000677	CbGpPWpGaD
Pasireotide—Nausea—Betamethasone—atopic dermatitis	0.000371	0.000823	CcSEcCtD
Pasireotide—Nausea—Dexamethasone—atopic dermatitis	0.000371	0.000823	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—IL5—atopic dermatitis	0.000368	0.000671	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—CCR5—atopic dermatitis	0.000366	0.000666	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CCR3—atopic dermatitis	0.000364	0.000663	CbGpPWpGaD
Pasireotide—Dizziness—Prednisone—atopic dermatitis	0.00036	0.000798	CcSEcCtD
Pasireotide—SSTR5—Signaling Pathways—NPS—atopic dermatitis	0.000351	0.00064	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TAC1—atopic dermatitis	0.000351	0.00064	CbGpPWpGaD
Pasireotide—Vomiting—Prednisone—atopic dermatitis	0.000346	0.000767	CcSEcCtD
Pasireotide—SSTR5—Signaling Pathways—CXCR3—atopic dermatitis	0.000345	0.000628	CbGpPWpGaD
Pasireotide—Headache—Prednisone—atopic dermatitis	0.000341	0.000756	CcSEcCtD
Pasireotide—SSTR2—Signaling by GPCR—CCR5—atopic dermatitis	0.000337	0.000615	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CXCL10—atopic dermatitis	0.000327	0.000597	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IL5—atopic dermatitis	0.000327	0.000595	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TAC1—atopic dermatitis	0.000324	0.000591	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—NPS—atopic dermatitis	0.000324	0.000591	CbGpPWpGaD
Pasireotide—Nausea—Prednisone—atopic dermatitis	0.000323	0.000716	CcSEcCtD
Pasireotide—SSTR2—Signaling Pathways—CXCR3—atopic dermatitis	0.000318	0.000579	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CXCL10—atopic dermatitis	0.000314	0.000572	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IL5—atopic dermatitis	0.000301	0.000549	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000286	0.000522	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CCL5—atopic dermatitis	0.000282	0.000514	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CXCL10—atopic dermatitis	0.000278	0.000507	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000274	0.0005	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—IL2—atopic dermatitis	0.000274	0.000498	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CCL5—atopic dermatitis	0.00027	0.000492	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—IL2—atopic dermatitis	0.000262	0.000478	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—NGF—atopic dermatitis	0.000261	0.000476	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—CXCL8—atopic dermatitis	0.00026	0.000474	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CXCL10—atopic dermatitis	0.000257	0.000468	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CCR5—atopic dermatitis	0.000254	0.000463	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—NGF—atopic dermatitis	0.00025	0.000456	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—CXCL8—atopic dermatitis	0.000249	0.000454	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—IL2—atopic dermatitis	0.000248	0.000453	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CCR5—atopic dermatitis	0.000243	0.000444	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000243	0.000443	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CCL5—atopic dermatitis	0.00024	0.000437	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—IL2—atopic dermatitis	0.000238	0.000434	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—IL2—atopic dermatitis	0.000233	0.000424	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000225	0.000409	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—NGF—atopic dermatitis	0.000222	0.000404	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CCL5—atopic dermatitis	0.000221	0.000403	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—CXCL8—atopic dermatitis	0.000221	0.000403	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CCR5—atopic dermatitis	0.000216	0.000393	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—NFKBIA—atopic dermatitis	0.000215	0.000392	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—IL2—atopic dermatitis	0.000215	0.000391	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—IL2—atopic dermatitis	0.000211	0.000385	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—NFKBIA—atopic dermatitis	0.000206	0.000376	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—NGF—atopic dermatitis	0.000205	0.000373	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—CXCL8—atopic dermatitis	0.000204	0.000372	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CCR5—atopic dermatitis	0.000199	0.000363	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—IL2—atopic dermatitis	0.000195	0.000355	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—NFKBIA—atopic dermatitis	0.000183	0.000334	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—NFKBIA—atopic dermatitis	0.000169	0.000308	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CXCL8—atopic dermatitis	0.000154	0.00028	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CXCL8—atopic dermatitis	0.000147	0.000268	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—IL2—atopic dermatitis	0.000147	0.000267	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—IL6—atopic dermatitis	0.000146	0.000266	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—IL2—atopic dermatitis	0.000141	0.000256	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—IL6—atopic dermatitis	0.00014	0.000255	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MAPK8—atopic dermatitis	0.000135	0.000246	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CXCL8—atopic dermatitis	0.000131	0.000238	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MAPK8—atopic dermatitis	0.000129	0.000236	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IL2—atopic dermatitis	0.000125	0.000227	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—IL6—atopic dermatitis	0.000124	0.000226	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CXCL8—atopic dermatitis	0.00012	0.00022	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IL2—atopic dermatitis	0.000115	0.00021	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MAPK8—atopic dermatitis	0.000115	0.000209	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—IL6—atopic dermatitis	0.000115	0.000209	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MAPK8—atopic dermatitis	0.000106	0.000193	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—IL6—atopic dermatitis	8.63e-05	0.000157	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—IL6—atopic dermatitis	8.27e-05	0.000151	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IL6—atopic dermatitis	7.33e-05	0.000134	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IL6—atopic dermatitis	6.77e-05	0.000123	CbGpPWpGaD
